Tohyama, Osamu
Eisai (Japan)
2 papers on CoChat
Most cited papers
- Verified
Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage.
Yamamoto, Y., Matsui, J., Matsushima, T., Obaishi, H., Miyazaki, K., Nakamura, K., Tohyama, O., Semba, T., Yamaguchi, A., Hoshi, S., et al. (2014) · Vascular Cell
Angiogenesis and VEGF in CancerLymphatic System and Diseases
Cited by 507
- Verified
Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models.
Tohyama, O., Matsui, J., Kodama, K., Hata-Sugi, N., Kimura, T., Okamoto, K., Minoshima, Y., Iwata, M., & Funahashi, Y. (2014) · Journal of Thyroid Research
Thyroid Cancer Diagnosis and TreatmentAngiogenesis and VEGF in Cancer
Cited by 475
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free